Neuropathy and quality of life in diabetic continuous ambulatory peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Apostolou, Theofanis ^a   Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diabetes; Diabetic complications; Neuropathy; Quality of life

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; GLYCOPYRRONIUM BROMIDE; LOPERAMIDE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTANOID; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE DURATION; FOOT AMPUTATION; GASTROINTESTINAL DISEASE; HIGH RISK PATIENT; HUMAN; IMPOTENCE; KIDNEY FAILURE; MORBIDITY; NEUROGENIC BLADDER; NEUROPATHIC JOINT DISEASE; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSORY NEUROPATHY; SURVIVAL RATE; SWEAT GLAND DISEASE; VISCERA;

EID: 0033374923     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s41     Document Type: Conference Paper

References (42)

1. Burn DJ, Bates D. Neurological and psychiatric disorders. In: Jamison RL, Wilkinson R, eds. Nephrology. London, U.K.: Chapman & Hall Publications; 1997:412-27.
2. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ. The Rochester Diabetic Study: Reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992; 42:1164-70.
3. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36:150-4.
4. Lee BC, Tooke JE. An overview of diabetic complications. In: Boulton AJM, ed. Diabetic Neuropathy. Exeter: Marius Press Publications; 1997:21-39.
5. Watkins PJ. The enigma of autonomic failure in diabetes. J R Coll Physicians Lond. 1998; 32:360-5.
6. Veves A, Webster L, Chen TF, Payne S, Boulton AJM. Aetiopathogenesis and management of impotence in diabetic males: Four years experience from a combined clinic. Diabet Med. 1995; 12:77-82.
7. Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJM. Gustatory sweating in diabetes mellitus. Diabet Med. 1996; 13:1033-7.
8. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJM. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia. 1997; 40:299-301.
9. Caddick SL, Ibrahim S, Ward JD. The management of diabetic neuropathy. In: Boulton AJM, ed. Diabetic Neuropathy. Exeter: Marius Press Publications; 1997: 147-57.
10. Kvinesdal B, Mollin J, Frolland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA. 1984; 251:1727-30.
11. Sindrup SH, Grodum E, Gram LF, Beck-Nielsen H. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Ther Drug Monit. 1991; 13:408-14.
12. Chakrabarti AK, Saamantary SK. Diabetic neuropathy: Nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med. 1976; 6:565-8.
13. Kastrup J, Angelo H, Petersen P, Dejgard A, Hilsted J. Treatment of chronic painful neuropathy with intravenous lidocaine infusion. Br Med J. 1986; 292:173-6.
14. Tesfaye S, Price DE. Therapeutic approaches in diabetic neuropathy and neuropathic pain. In: Boulton AJM, ed. Diabetic Neuropathy. Exeter: Marius Press Publications; 1997:159-81.
15. Abuaisha BB, Costanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: A long term study. Diabetes Res Clin Pract. 1998; 39:115-21.
16. Cameron NE, Cotter MA. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: Evidence from experimental studies. Diabet Med. 1993; 10:595-605.
17. Fernando DJS, Hutchison AJ, Veves A, Gokal R, Boulton AJM. Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med. 1991; 8:223-5.
18. Boulton AJM. End-stage complications of diabetic neuropathy: Foot ulceration. Can J Neurol Sci. 1994; 21(Suppl 4):S18-22.
19. Boulton AJM. Late sequelae of diabetic neuropathy. In: Boulton AJM, ed. Diabetic Neuropathy. Exeter: Marius Press Publications; 1997:63-75.
20. Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998; 15:508-14.
21. Thomson FJ, Veves A, Ashe H, Knowles EA, Gem J, Walker MG, et al. A team approach to diabetic foot care - The Manchester experience. The Foot. 1991; 2:75-82.
22. Shaw JE, Boulton AJM, Gokal R. Management of foot problems in diabetes. Perit Dial Int. 1996; 16(Suppl 1): S279-82.
23. Selby PL, Young MJ, Boulton AJM. Biphosphonates: A new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994; 11:28-31.
24. Shaw JE, Gokal R, Hollis S, Boulton AJM. Does peripheral neuropathy invariably accompany nephropathy in type I diabetes mellitus? Diabetes Res Clin Pract. 1998; 39:55-61.
25. Pugh JA, Medina R, Ramirez M. Comparisons of the course to end-stage renal disease of type I and type II diabetic nephropathy. Diabetologia. 1993; 36:1094-8.
26. Kennedy WR, Navarro X, Sutherland DE. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology. 1995; 45:773-80.
27. Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardio-respiratory reflexes, nerve conduction and mortality in diabetes mellitus. Diabetes. 1990; 39:802-6.
28. Hauner H, Schubert J, Pfeiffer EF. Prevalence of secondary complications in patients with type I diabetes mellitus. A retrospective analysis of 549 type I diabetic patients of the Ulm University clinic. Med Klin. 1990; 85:690-5.
29. Gokal R. Quality of life. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1994:679-98.
30. Balaskas EV, Yuan ZY, Gupta A, Meema HE, Blair G, Bargman J, et al. Long term continuous ambulatory peritoneal dialysis in diabetics. Clin Nephrol. 1994; 42:54-62.
31. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al. Ten years experience of CAPD in diabetics: Comparison of results with non diabetics. Nephrol Dial Transplant. 1994; 9:1443-8.
32. Yu CC, Wu MS, Wu CH, Yang CW, Huang JY, Hong JJ, et al. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on CAPD. Perit Dial Int. 1997; 17:262-8.
33. Tzamaloukas AH, Yuan ZY, Murata GH, Balaskas E, Avasthi PS, Oreopoulos DG. Clinical associations of glycemic control in diabetics on CAPD. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1993; 9:291-4.
34. Amair P, Khanna R, Leibel B, Pierratos A, Vas S, Meema E, et al. CAPD in diabetics with end-stage renal disease. N Engl J Med. 1982; 306:625-630.
35. Abdel-Rahman EM, Wakeen M, Zimmerman SW. Characteristics of long term peritoneal dialysis survivors: 18 years experience in one center. Perit Dial Int. 1997; 17:151-6.
36. Marcelli D, Spotti D, Conte F, Tagliaferro A, Limido A, Lonati F, et al. Survival of diabetic patients on peritoneal dialysis or hemodialysis. Perit Dial Int. 1996; 16(Suppl 1):S283-7.
37. Maiorca R, Vonesh EF, Cavalli PL, De Vecchi A, Giangrande A, LaGreca G, et al. A multicenter selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int. 1991; 11:118-27.
38. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Markers for survival in dialysis. A seven-year prospective study. Am J Kidney Dis. 1995; 26:209-19.
39. Jacobs C, Selwood NH. Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade. Am J Kidney Dis. 1995; 25:188-95.
40. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. CAPD and haemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994; 45:1163-9.
41. Reichard P, Nilson BY, Rosenqvist U. The effect of long term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993; 329:304-9.
42. Wolfe RA, Port FK, Hawthorn VM, Guire KE. A comparison of survival among dialytic therapies of choice: In-center haemodialysis versus CAPD at home. Am J Kidney Dis. 1990; 15:433-40.